Zini Tanzi, Gina
 Distribuzione geografica
Continente #
NA - Nord America 5.632
EU - Europa 5.476
AS - Asia 3.452
SA - Sud America 713
Continente sconosciuto - Info sul continente non disponibili 156
AF - Africa 97
OC - Oceania 14
Totale 15.540
Nazione #
US - Stati Uniti d'America 5.441
DE - Germania 1.748
IT - Italia 1.481
SG - Singapore 1.440
CN - Cina 897
BR - Brasile 564
SE - Svezia 520
VN - Vietnam 355
FR - Francia 351
GB - Regno Unito 312
UA - Ucraina 285
IE - Irlanda 163
ID - Indonesia 142
PL - Polonia 142
FI - Finlandia 134
IN - India 134
CA - Canada 85
NL - Olanda 79
JP - Giappone 74
RU - Federazione Russa 72
HK - Hong Kong 70
AR - Argentina 53
TR - Turchia 53
MX - Messico 48
BD - Bangladesh 43
BE - Belgio 40
IQ - Iraq 37
ES - Italia 25
EC - Ecuador 23
IR - Iran 23
PK - Pakistan 23
CO - Colombia 22
ZA - Sudafrica 22
SA - Arabia Saudita 21
AT - Austria 19
MY - Malesia 17
CH - Svizzera 15
PE - Perù 15
VE - Venezuela 15
LT - Lituania 14
PH - Filippine 14
AU - Australia 13
MA - Marocco 13
PT - Portogallo 13
CI - Costa d'Avorio 12
HN - Honduras 12
KE - Kenya 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
JO - Giordania 11
KR - Corea 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
RO - Romania 9
CL - Cile 8
JM - Giamaica 8
EG - Egitto 7
DZ - Algeria 6
EE - Estonia 6
GE - Georgia 6
GR - Grecia 6
CR - Costa Rica 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
PY - Paraguay 5
TN - Tunisia 5
YE - Yemen 5
AL - Albania 4
BH - Bahrain 4
ET - Etiopia 4
KG - Kirghizistan 4
LB - Libano 4
NG - Nigeria 4
NO - Norvegia 4
PA - Panama 4
PR - Porto Rico 4
PS - Palestinian Territory 4
QA - Qatar 4
TW - Taiwan 4
AM - Armenia 3
AO - Angola 3
BG - Bulgaria 3
BZ - Belize 3
GT - Guatemala 3
LV - Lettonia 3
NI - Nicaragua 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
GH - Ghana 2
GP - Guadalupe 2
LK - Sri Lanka 2
LY - Libia 2
MK - Macedonia 2
OM - Oman 2
Totale 15.357
Città #
Singapore 721
Chandler 631
Ashburn 601
San Jose 410
Beijing 196
Jacksonville 190
Ann Arbor 169
San Mateo 168
Milan 166
Dublin 161
Rome 161
Dearborn 148
Los Angeles 145
Nanjing 142
Warsaw 117
Jakarta 110
New York 109
Hanoi 106
Dallas 104
Nürnberg 104
Ho Chi Minh City 102
Lauterbourg 85
Cattolica 81
Woodbridge 81
Munich 80
Wilmington 75
Boston 71
Frankfurt am Main 68
Lawrence 65
Houston 63
Council Bluffs 62
Redmond 60
Seattle 60
Tokyo 60
Fairfield 59
Bremen 54
Hong Kong 54
The Dalles 54
São Paulo 52
Nanchang 51
Santa Clara 50
Lancaster 49
Marseille 48
Redwood City 48
Hefei 47
Naples 44
Brussels 38
Moscow 37
Helsinki 36
Hangzhou 35
Chicago 33
Florence 32
Bologna 31
London 31
Paris 29
Brooklyn 28
Izmir 28
Norwalk 27
Palermo 27
Boardman 26
Toronto 26
Mountain View 25
Buffalo 24
Leawood 24
Montreal 24
Orem 24
Princeton 24
Rio de Janeiro 24
Shenyang 24
Turin 24
Zhengzhou 23
Da Nang 22
Kunming 22
San Francisco 22
Shanghai 22
Phoenix 21
Tianjin 21
Turku 20
Atlanta 19
Cagliari 19
Denver 19
Jiaxing 19
Guangzhou 18
Las Vegas 18
Augusta 17
Baghdad 17
Columbus 17
Hebei 17
Düsseldorf 16
Pune 16
Cambridge 15
Haiphong 15
Mexico City 15
Falls Church 14
Philadelphia 14
University Park 14
Amsterdam 13
Genoa 13
Hyderabad 13
Johannesburg 13
Totale 7.487
Nome #
MORFOLOGIA DELLE MALATTIE DEL SANGUE Verduci Editore 1.249
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 391
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 371
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 354
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features 315
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 304
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 299
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 247
Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants 233
Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants 226
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 216
Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia 214
Weak D Type 4.2.2 (DAR1.2) in an African child: Serology and molecular characterization 206
Morphology of Blood Disorders 201
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 199
Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors 198
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 198
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 191
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 190
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 189
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 188
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 187
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 186
Hypoxia-inducible factor-1α(Pro-582-Ser) polymorphism prevents iron deprivation in healthy blood donors 182
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 180
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 179
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 172
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 172
TWO-GROUP STUDY OF MEDIAL MICROSCOPY AS A ROBUST TOOL TO HARMONIZE AND STANDARDIZE HAEMATOLOGICAL DIAGNOSIS 169
Allogeneic umbilical cord blood red cell concentrates: An innovative blood product for transfusion therapy of preterm infants 169
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 168
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 165
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 163
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 162
The role of molecular typing and perfect match transfusion in sickle cell disease and thalassaemia: An innovative transfusion strategy 162
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 161
Analysis of bone marrow aspiration fluid using automated blood cell counters. 160
Transfusion of very low birth weight neonates using allogeneic cord blood derived RBC units. 157
Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria. 153
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 152
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 149
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 148
Allogeneic cord blood red cells for transfusion 144
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 143
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 140
Primary myelofibrosis: when the clone manifests with Rh phenotype splitting 139
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes 138
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 138
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 137
Poor mobilizer: a retrospective study on proven and predicted incidence according to GITMO criteria 137
Increased levels of solubile intercellular adhesion molecole-1, neutrophils and elastase in the lung of preterm infants with bronchopulmonary displasia. 135
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 135
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 131
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 131
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 131
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 126
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 124
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions 124
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 123
Fechtner syndrome: report of a third family and literature review 121
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 121
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial 121
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 116
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 115
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 115
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 115
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 112
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 110
Medicine use in pregnancy and public cord blood bank databases 109
Fragmented red blood cells automated measurement is a useful parameter to exclude schistocytes on the blood film 107
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 107
Leukemia diagnosis: today and tomorrow 106
Inline extracorporeal photopheresis: evaluation of cell collection efficiency 106
Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas 105
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? 103
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 98
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 97
The concomitance of lymphoma and breast carcinoma in the bone 97
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 96
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance 94
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 92
Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia 90
Diagnostics and prognostication of myelodysplastic syndromes 90
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets 88
CELL-BY-CELL ASSESSMENT OF MEDIAL MICROSCOPY (MM) AS A BETWEEN-OBSERVER TOOL FOR HARMONIZATION AND PROFICIENCY TESTING (ON BEHALF OF WP10 LEUKEMIANET DIAGNOSIS MORPHOLOGICAL FACULTY) 88
Case of metastatic melanoma in bone marrow smear 80
Innovation in hematology: Morphology and flow cytometry at the crossroads 80
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 77
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 73
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 73
ICSH: on board for new projects 72
Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients 71
Schistocytes 69
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 68
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 68
Research in morphology and flow cytometry is at the heart of hematology 63
INTRODUCTION 62
The risk of thrombosis in patients with acute leukemia: Occurrence of thrombosis at diagnosis and during treatment 7
Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies 3
Bulky lymphadenopathy in acute myeloid leukemia 3
Totale 15.539
Categoria #
all - tutte 58.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022746 0 0 0 49 75 37 30 157 34 52 130 182
2022/20231.835 207 255 143 283 132 229 76 168 232 28 51 31
2023/2024953 54 250 33 64 48 135 86 26 22 37 102 96
2024/20252.034 44 71 147 100 216 98 91 96 277 206 391 297
2025/20264.407 707 133 262 400 687 241 832 225 285 340 178 117
2026/2027804 295 158 287 64 0 0 0 0 0 0 0 0
Totale 15.540